Minimum Residual Disease in Acute Lymphoblastic Leukemia
5 Bekeken
• 08/04/23
0
0
insluiten
administrator
abonnees
In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties